Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Certara Inc (NQ: CERT )

16.43 +0.33 (+2.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 724,878
Open 16.10
Bid (Size) 16.41 (12)
Ask (Size) 16.43 (25)
Prev. Close 16.10
Today's Range 16.04 - 16.56
52wk Range 11.81 - 24.96
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies 
From Certara
Via GlobeNewswire
Recap: Certara Q3 Earnings
Via Benzinga

Performance

YTD
+1.17%
+1.17%
1 Month
+21.70%
+21.70%
3 Month
+12.84%
+12.84%
6 Month
-7.64%
-7.64%
1 Year
-3.35%
-3.35%

More News

Read More
Certara Reports Third Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
From Certara
Via GlobeNewswire
The Latest Analyst Ratings for Certara
Via Benzinga
The Latest Analyst Ratings for Certara
Via Benzinga
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
From Certara
Via GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Certara Simcyp™ Group Awarded Two New Grants from US FDA
From Certara
Via GlobeNewswire
Looking Into Certara's Return On Capital Employed
Via Benzinga
Analyst Expectations for Certara's Future
Via Benzinga
Expert Ratings for Certara
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Certara Reports Second Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
From Certara
Via GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Certara Reports First Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
From Certara
Via GlobeNewswire
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
From Certara
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Via Benzinga
Are These 3 Small Momentum Stocks Setting Up Big Gains?
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.